Fibre reinforced bioresorbable composites for spinal surgery
Source abstract
Abstract
Composites containing different amounts of beta-tricalcium phosphate (beta-TCP) embedded in a poly-lactide (PLA70) matrix with and without poly-lactide (PLA96) fibre reinforcement were studied and the feasibility of using these composites in spinal fusion implants was examined. Compressive yield strength was measured in two directions: parallel to (83-97 MPa) and perpendicular to (108-123 MPa) the laminated structure of the composites. In the parallel direction, the addition of beta-TCP decreased compressive yield strength while in the perpendicular direction this was increased when compared to plain specimens (p<0.05). Fibre reinforcement had no significant effect on compressive yield strength (p<0.05), but did increase impact strength by 127-216% for notched specimens (parallel direction) and by about 65% for un-notched specimens (perpendicular direction) (p<0.05). A 24 week in vitro analysis of implant prototypes in simulated body fluid revealed a decrease in compressive yield strength, which was greater for the samples containing 50 wt.% beta-TCP than for those containing 25 wt.% beta-TCP. After 12 weeks incubation the composites retained 66-99% of their initial compressive strength, depending on composition. After 24 weeks incubation the lowest compressive strength was 51% (56 MPa: 50/50) and the highest was 94% (90 MPa: 75/25) of the initial value. Calcium phosphate precipitation on the surfaces of the materials in vitro was also observed. The initial compressive strengths of the studied composites were comparable to materials used in spinal fusion applications, but adequate strength retention behaviour needs to be confirmed before undertaking clinical experiments.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Spine and Intervertebral Disc Pathology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. The artificial disc: theory, design and materials10.1016/0142-9612(96)84936-2 ↗
2. Physician office visits for low back pain10.1097/00007632-199501000-00003 ↗
3. Biomedical materials. May 2003:2–3.
4. MedPro Month. Volume XII March 2002;3:10–12.
5. Lowe TG. Degenerative disc disease and low back pain. Available from: http://www.spineuniverse.com/displayarticle.php/article242.html (05272005).
6. Sasso RC. Screws, Cages or Both? Available from: http://www.spineuniverse.com/displayarticle.php/article1363.html (05272005).
7. Materials and design of spinal implants – a review10.1002/(SICI)1097-4636(199723)38:3<267::AID-JBM12>3.0.CO;2-8 ↗
8. Prospective controlled study of titanium cage fusion compared with iliac crest autograft fusion in anterior cervical discectomy
9. Biomedical Materials. October 2001:2.
10. Mechanical evaluation of novel interbody fusion cages made of bioactive, resorbable composites10.1016/S0142-9612(03)00155-8 ↗
11. Mechanischer Verleich Biodegradierberer Intervertebraler Lumbaler Cages10.1007/s001040170007 ↗
12. The use of poly-l-lactic acid in lumbar interbody cages: design and biomechanical evaluation in vitro10.1007/s00586-002-0458-y ↗
13. Bioabsorbable poly-l-lactic acid cages for lumbar interbody fusion: three year follow-up radiographic, histologic, and histomorphometric analysis in goats10.1097/00007632-200212010-00010 ↗
14. Novel bioabsorbable interbody fusion spacer-assisted fusion for correction of spinal deformity10.3171/foc.2003.14.1.12 ↗
15. In vitro and in vivo degradation of bioabsorbable PLLA spinal fusion cages10.1002/jbm.10466 ↗
16. Spinal applications of bioabsorbable implants
17. Evaluation of 70/30 poly(l-lactide-co-d,l-lactide) for use as a resorbable interbody fusion cage
18. Resorbable cages for spinal fusion: an experimental goat model
19. The effect of cage stiffness on the rate of lumbar interbody fusion: an in vivo model using poly(l-lactic acid) and titanium cages10.1097/00007632-200204010-00003 ↗
20. Resorbable polymer implants in unilateral transforaminal lumbar interbody fusion
21. Applications of a resorbable interbody spacer in posterior lumbar interbody fusion
22. Computerized tomography evaluation of a resorbable implant after transforaminal lumbar interbody fusion10.3171/foc.2004.16.3.11 ↗
23. Posterior lumbar interbody fusion with bioabsorbable spacers and local autograft in a series of 27 patients10.3171/foc.2004.16.3.9 ↗
24. Early findings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein-2 was used with poly(l-lactide-co-d,l-lactide) bioabsorbable implants10.3171/foc.2004.16.3.7 ↗
25. Lumbar interbody fusion after treatment with recombinant human bone morphogenetic protein-2 added to 70:30 poly(l-lactide-co-d,l-lactide) bioresorbable implants10.3171/foc.2004.16.3.10 ↗
26. Instrumented transforaminal lumbar interbody fusion with bioabsorbable polymer implants and iliac crest autograft10.3171/foc.2004.16.3.12 ↗
27. Cervical spine fusion with bioabsorbable cages10.3171/foc.2004.16.3.5 ↗
28. Anterior cervical interbody fusion with hydroxyapatite graft and plate system10.3171/foc.2001.10.4.9 ↗
29. Instrumented posterolateral lumbar fusion using coralline hydroxy apatite with or without demineralized bone matrix, as an adjunct to autogenous bone10.1016/S1529-9430(01)00011-0 ↗
30. In vivo evaluation of calcium sulfate as a bone graft substitute for spinal fusion10.1016/S1529-9430(01)00108-5 ↗
31. The use of carbon fibre cages in anterior cervical interbody fusion, report of 100 cases10.3171/foc.2002.12.1.2 ↗
32. A biomechanical and histological evaluation of a bioresorbable lumbar interbody fusion cage10.1016/j.biomaterials.2004.07.020 ↗
33. Outcomes of allogenic cages in anterior and posterior lumbar interbody fusion
34. Bioresorbable polymers in trauma and bone surgery10.1016/S0020-1383(00)80020-0 ↗
35. Contemporary concepts in spine care: intervertebral cages for degenerative spinal diseases10.1016/S1529-9430(03)00004-4 ↗
36. Surgical interbody research group – radiographic assessment of interbody fusion devices: fusion criteria for anterior lumbar interbody surgery10.3171/foc.2001.10.4.12 ↗
37. Biomechanical analysis of biodegradable interbody fusion cages augmented with poly(propylene glycol-co-fumaric acid)10.1097/00007632-200208010-00010 ↗
38. Lumbar intervertebral disc replacement using bioabsorbable self-reinforced poly-l-lactide full-threaded screws, or cylindrical implants of polylactide polymers, bioactive glass and polyactiveTM
39. Hench · 1993
40. A new intervertebral disc replacing biomaterial: open porous, hydroxyapatite filled polymethylmethacrylate
41. Processing of resorbable poly-α-hydroxy acids for use as tissue-engineering scaffolds
42. ISO 604:2002(E). Plastics—Determination of compressive properties. International Organization of Standardization 1993. p. 1–9.
43. ISO 180:2000. Plastics—Determination of Izod impact strength. International Organization of Standardization 2000. p. 1–10.
44. Pliable polylactide plates for guided bone regeneration: manufacturing and in vitro10.1243/0954411001535642 ↗
45. Solutions able to reproduce in vivo surface-structure changes in bioactive glass ceramic A–W10.1002/jbm.820240607 ↗
46. US Food and Drug Administration, Guidance document for testing biodegradable polymer implant devices (Draft), 1996.
47. A/W Glass–ceramic: processing and properties
48. Bioresorbable devices made of forged composites of hydroxyapatite (HA) particles and poly-l-lactide (PLLA): Part I. Basic characteristics10.1016/S0142-9612(98)00241-5 ↗
49. PEEK all, Custom Cutting Technologies Inc., Available from: http://www.cctplastics.com/peekall.html (03142006).
50. White · 1990
51. Mechanical properties of human lumbar spine motion segments: influence of age, sex, disc level and degeneration10.1097/00007632-197901000-00001 ↗
52. Strength and stability of posterior lumbar interbody fusion10.1097/00007632-199706010-00002 ↗
53. Cornwall GB, Thomas KA, McManus AJ, Moser RC, Kisselburgh C. Compressive strength retention of 70:30 poly(l-lactide-co-d,l-lactide) following real time agening. Society for biomaterials 29th annual meeting transactions. p. 393.
54. Bioresorbable fibre reinforced composites for spinal fusion application: in vitro analysis
55. ASTM F2077-03 Test methods for intervebral body fusion devices, Conshohocken, PA, ASTM International, p. 1–9.